Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)

Part of paid clinical trials in Chicago, Illinois.

Sponsor
Alzheimer's Disease and Related Disorders Association, Inc
Study ID
NCT06170268
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Routine Care Documentation — OTHER
    Routine Care Documentation

Study Details

The Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) will collect longitudinal clinical and safety data for enrolled patients being evaluated for or treated with novel FDA-approved Alzheimer's disease (AD) therapies. ALZ-NET is a longitudinal registry with an expandable platform, designed to grow with scientific and medical advancements. As new treatments are approved and implemented in care, ALZ-NET will track the long-term health outcomes associated with their use in a real-world setting. ALZ-NET is a resource for evidence gathering, information sharing and education across clinical and research communities, encouraging innovative research and supporting opportunities to improve clinical care delivery. All participating physicians and site staff will complete comprehensive training to ensure adherence of data requirements and registry timelines.

Key Dates

Start date
Oct 20, 2022
Status verified
Nov 2023
Primary completion
Dec 31, 2032
Completion
Dec 31, 2032

Study Design

Enrollment
20,000 participants (estimated)

Arms

  • Arm: Not Applicable/Open Label Registry
    ALZ-NET is a growing network of sites that follow participants over time with an expandable platform, allowing for the collection of real-world data from enrolled patients being evaluated for or receiving any novel FDA-approved Alzheimer's disease therapies. ALZ-NET is treatment agnostic. Drug treatment dosage, frequency and duration will be guided by FDA label and clinician judgment as part of treatment and patient management.

Primary Outcome Measure

Evaluate whether FDA-approved treatments improve health outcomes (as measured by slowing of cognitive decline) over time in a real-world population in broad clinical settings. [ Time Frame: 2 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Full List of Active SitesChicagoIllinois60601
Go to Site Finder https://www.alz-net.org/Find-a-Site
[email protected]
215-574-3181

Find similar trials in Chicago, IL

By condition
Alzheimer's disease
By specialty
NeurologyDementia careBrain disordersGeriatrics
By research site
Full List of Active Sites· Chicago, IL

Related Studies